Opella is the self-care challenger with the purest and third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health in people’s hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting. At the core of this mission is our 100 loved brands, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many of the world’s most loved brands, including Allegra, Buscopan, Doliprane, Dulcolax, Enterogermina, Essentiale and Mucosolvan. As a globally certified B Corp company, we are active players in the journey towards healthier people and planet. Find out more about our mission on our website.
| Website | https://www.opella.com/ |
| Revenue | $5.5 billion |
| Employees | 4,826 (2,315 on RocketReach) |
| Industry | Retail Health and Personal Care Products |
| Keywords | Over-The-Counter Medications, Consumer Healthcare, Non-Prescription Drugs, Otc Products, Vitamins, Minerals, Supplements, Health Supplements, Dietary Supplements, Nutritional Supplements, Wellness Products, Health And Wellness, Personal Care, Natural Remedies, Herbal Remedies, Home Healthcare, Alternative Medicine |
| Competitors | Amgen, Bristol Myers Squibb, Gilead Sciences, Vertex Pharmaceuticals, Regeneron, Spark Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Editas Medicine, Northwest Biotherapeutics, Axovant Sciences Ltd +47 more (view full list) |
Looking for a particular Opella employee's phone or email?
The Opella annual revenue was $5.5 billion in 2026.
Julie van Ongevalle is the Opella President and Chief Executive Officer of Opella.
2,315 people are employed at Opella.